Stay updated on Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4, indicating a deployment/update of the site's underlying tooling. This update does not change the study data, eligibility criteria, results, or visible content on the page.
    Difference
    0.0%
    Check dated 2026-08-10T11:58:44.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The Study Details page updated its revision label from v3.6.3 to v3.6.4, representing a small page patch rather than new or altered study information.
    Difference
    0.0%
    Check dated 2026-07-27T05:43:18.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.3, indicating a small publishing update to the page's version rather than changes to the study data or displayed content.
    Difference
    0.0%
    Check dated 2026-07-05T13:33:49.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study details page revision tag was updated from v3.6.0 to v3.6.2, signaling a small maintenance update to the page’s underlying system.
    Difference
    0.0%
    Check dated 2026-06-28T08:16:15.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study record now indicates it is not actively enrolling participants and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study); the revision tag was updated to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.4%
    Check dated 2026-06-14T04:48:54.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a minor maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-06-07T00:19:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.